Applied Nanotech Holdings, Inc. this morning announced the formation of a special advisory committee to the Board of Directors that will assist in formulating and implementing business development activities. This new committee will be headed by Director Paul Rocheleau and will also include board member Clint Everton and members of management. In the near future, the company plans to add other qualified outsiders.

“We have a greater breadth of technology and more opportunities than at any time in the history of the company,” stated Doug Baker, Chief Executive Officer of APNT. “The most important thing that we can do now to take advantage of those opportunities is to make sure that we focus our resources on bringing in revenue to bring us to profitability.”

“I look forward to helping the Company realize its full potential and begin commercializing its technology,” commented Paul Rocheleau, Director of APNT. “With a concentrated focus,

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Thursday August 20, 2009

PennyOmega.com Stock Report!

**************************************************************

Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that it has been selected by the U.S. Department of Energy to receive a contract of approximately $750,000 for the development of non-contact, printable metallic inks for silicon solar cells.

MedLink International, Inc. (OTCBB: MLKNA) is pleased to announce the appointment of Abha Agrawal, MD, FACP to the company’s Medical Advisory Board. Dr. Agrawal is the Interim Medical Director of Kings County Hospital Center, Brooklyn, NY. Prior to this role, she was the Chief Medical Information Officer of the Central Brooklyn Family Health Network (CBFHN) and the Associate Medical Director of Kings County

Applied Nanotech Holdings, Inc. announced this morning the signing of an exclusive worldwide license agreement with a leading industrial chemical products company in Japan for manufacturing and commercializing nano-copper inks and pastes. The company will receive an upfront payment of $1.5 million, of which $500,000 is payable immediately, and $1.0 million is payable in June 2010. Applied Nanotech will also receive a royalty of 4% of sales of the copper inks and pastes by its partner. Discussions for a new research and development contract have also begun.

“This is a giant step toward implementing our Technical Inks Printing Solution (’TIPS’) strategy based on five important modules: nanoparticles manufacturing, inks development and manufacturing, technical printing applications development, processing development, and adequate hardware. Securing a trusted, high quality technology partner with a broad base of products used in electronic applications plays a vital role in our approach,” stated Dr. ZviYaniv, Chief Executive

In the last several decades, the world has been introduced to several basic technology advances. These advances were the very minimum advances needed to spawn entirely new markets. They were also based on fairly simple premises, premises that had been locked away waiting to be found, understood and utilized. As these basics were understood and brought to market, many ways to profit from them were found. These opportunities might have included licenses or downstream applications. An investor that can find a company, at the right stage of basic discovery advance and commercialization, is the investor that will profit significantly.

Applied Nanotech Holdings Inc., a technology research and commercialization holding company, works to develop and license new and patented products through two wholly owned subsidiaries. The company directs its activities primarily toward nanotechnologies (nanotechnology, in its simplest possible definition, involves the building of physical 3D structures, such as tubes, from individual molecules.)

The